Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs
暂无分享,去创建一个
Martin L. Miller | Aly A. Khan | C. Sander | C. Leslie | D. Marks | Doron Betel | D. Betel
[1] A. Wargelius,et al. Double-stranded RNA induces specific developmental defects in zebrafish embryos. , 1999, Biochemical and biophysical research communications.
[2] R. Ho,et al. Too much interference: injection of double-stranded RNA has nonspecific effects in the zebrafish embryo. , 2000, Developmental biology.
[3] B. Li,et al. Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.
[4] T. Hubbard,et al. A census of human cancer genes , 2004, Nature Reviews Cancer.
[5] F. Slack,et al. Architecture of a validated microRNA::target interaction. , 2004, Chemistry & biology.
[6] V. Ambros. The functions of animal microRNAs , 2004, Nature.
[7] Aimee L Jackson,et al. Noise amidst the silence: off-target effects of siRNAs? , 2004, Trends in genetics : TIG.
[8] Anton J. Enright,et al. Human MicroRNA Targets , 2004, PLoS biology.
[9] Lin He,et al. MicroRNAs: small RNAs with a big role in gene regulation , 2004, Nature reviews genetics.
[10] J. Castle,et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs , 2005, Nature.
[11] Jens Gruber,et al. RNAi of FACE1 protease results in growth inhibition of human cells expressing lamin A: implications for Hutchinson-Gilford progeria syndrome , 2005, Journal of Cell Science.
[12] N. Rajewsky,et al. Silencing of microRNAs in vivo with ‘antagomirs’ , 2005, Nature.
[13] L. Lim,et al. Position-specific chemical modification of siRNAs reduces "off-target" transcript silencing. , 2006, RNA.
[14] Theresa A. Storm,et al. Fatality in mice due to oversaturation of cellular microRNA/short hairpin RNA pathways , 2006, Nature.
[15] L. Lim,et al. Widespread siRNA "off-target" transcript silencing mediated by seed region sequence complementarity. , 2006, RNA.
[16] V. Velculescu,et al. Implications of micro-RNA profiling for cancer diagnosis , 2006, Oncogene.
[17] J. Lieberman,et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection , 2006, Nature.
[18] Xiaowei Wang,et al. Systematic identification of microRNA functions by combining target prediction and expression profiling , 2006, Nucleic acids research.
[19] Brian S. Roberts,et al. The colorectal microRNAome. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[20] Anne Gatignol,et al. Combinatorial delivery of small interfering RNAs reduces RNAi efficacy by selective incorporation into RISC , 2007, Nucleic acids research.
[21] David P. Bartel,et al. Supporting Online Material Materials and Methods Fig. S1 Tables S1 and S2 References Database S1 Disrupting the Pairing between Let-7 and Hmga2 Enhances Oncogenic Transformation , 2022 .
[22] Michael S. Goldberg,et al. Effective RNAi-mediated gene silencing without interruption of the endogenous microRNA pathway , 2007, Nature.
[23] L. Lim,et al. Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression , 2007, Molecular and Cellular Biology.
[24] L. Lim,et al. A microRNA component of the p53 tumour suppressor network , 2007, Nature.
[25] C. Sander,et al. A Mammalian microRNA Expression Atlas Based on Small RNA Library Sequencing , 2007, Cell.
[26] Michael A. Beer,et al. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. , 2007, Molecular cell.
[27] L. Lim,et al. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. , 2007, Molecular cell.
[28] Ralph Weissleder,et al. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. , 2007, Cancer research.
[29] W. Tam. The emergent role of microRNAs in molecular diagnostics of cancer. , 2008, The Journal of molecular diagnostics : JMD.
[30] Wandering eye for RNAi. , 2008, Nature medicine.
[31] Mauro Biffoni,et al. The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities , 2008, Nature Medicine.
[32] J. Stenvang,et al. Targeting of microRNAs for therapeutics. , 2008, Biochemical Society transactions.
[33] Oliver Hobert,et al. Molecular architecture of a miRNA-regulated 3' UTR. , 2008, RNA.
[34] G. Ruvkun. The perfect storm of tiny RNAs , 2008, Nature Medicine.
[35] Søren Brunak,et al. Cyclebase.org—a comprehensive multi-organism online database of cell-cycle experiments , 2007, Nucleic Acids Res..
[36] A. Silahtaroglu,et al. Antagonism of microRNA-122 in mice by systemically administered LNA-antimiR leads to up-regulation of a large set of predicted target mRNAs in the liver , 2007, Nucleic acids research.
[37] F. de Longueville,et al. Gene expression silencing with ‘specific’ small interfering RNA goes beyond specificity – a study of key parameters to take into account in the onset of small interfering RNA off‐target effects , 2008, The FEBS journal.
[38] A. Judge,et al. Misinterpreting the therapeutic effects of siRNA caused by immune stimulation , 2008 .
[39] Julang Li,et al. Adverse effects induced by short hairpin RNA expression in porcine fetal fibroblasts. , 2008, Biochemical and biophysical research communications.
[40] M. Zavolan,et al. Molecular characterization of human Argonaute-containing ribonucleoprotein complexes and their bound target mRNAs. , 2008, RNA.
[41] A. Judge,et al. Misinterpreting the therapeutic effects of small interfering RNA caused by immune stimulation. , 2008, Human gene therapy.
[42] Erratum: Wandering eye for RNAi , 2008, Nature Medicine.
[43] R. Knight,et al. Regions and Fewer MicroRNA Target Sites Proliferating Cells Express mRNAs with Shortened 3 ' Untranslated , 2012 .
[44] W. Filipowicz,et al. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? , 2008, Nature Reviews Genetics.
[45] N. Rajewsky,et al. Widespread changes in protein synthesis induced by microRNAs , 2008, Nature.
[46] S. Kauppinen,et al. LNA-mediated microRNA silencing in non-human primates , 2008, Nature.
[47] Brian L. Gilmore,et al. Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: Implications for the therapeutic development of RNAi , 2008, Proceedings of the National Academy of Sciences.
[48] E. Lane,et al. Therapeutic siRNAs for dominant genetic skin disorders including pachyonychia congenita. , 2008, Journal of dermatological science.
[49] M. Shibata,et al. Combination therapy with short interfering RNA vectors against VEGF-C and VEGF-A suppresses lymph node and lung metastasis in a mouse immunocompetent mammary cancer model , 2008, Cancer Gene Therapy.
[50] D. Bartel,et al. The impact of microRNAs on protein output , 2008, Nature.
[51] T. Baumert,et al. Club siRNA – a powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle , 2012 .
[52] M. Gait,et al. miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates. , 2007, RNA.
[53] P. Linsley,et al. MicroRNA-like off-target transcript regulation by siRNAs is species specific. , 2009, RNA.
[54] Andrea Ventura,et al. MicroRNAs and Cancer: Short RNAs Go a Long Way , 2009, Cell.
[55] Erratum: New relief for gout , 2009, Nature Biotechnology.